HI-Systems

Name: HI-Systems
Brand: HI-Systems

Uw partner in medicatiemanagement. Aanbieder van ICT-oplossingen voor iedere fase van de farmaceutische closed loop.

Est 1987|5 Ref Customers

LinkedIn 207|Website|FTEs 10|HQ Oosterhout, North Brabant, NL

Published Sep 19, 2026

01Common complaints

- When an organization requires a single-vendor, end-to-end EPD suite to minimize integration work - EPD-first vendors such as ChipSoft HiX or NEXUS may better support aggressive vendor consolidation strategies. - When the organization is a net-new customer seeking legacy modules - Zamicom and Klinicom are not available for new customers; selecting HI-Systems implies alignment with the ViPharma product direction and confirmation of migration tooling and feature parity. - When procurement requires publicly available security documentation - Public SOC 2/ISO 27001/NEN 7510 attestations were not found; security teams should request documentation under NDA. - When third-party review-platform coverage is a key part of vendor selection - HI-Systems has limited presence on mainstream review sites based on accessible searches; organizations that rely heavily on those platforms should plan additional reference checks. - Current limitations acknowledged by the vendor - Zamicom is not available for new customers. - Klinicom is not available for new customers. - Roadmap / future availability - No public roadmap with dates was identified in the sources reviewed. - Scale limitations - Not publicly documented; prospective customers should request scalability references if this is a concern. - Security or compliance gaps - Public-facing security certifications and detailed enterprise security feature disclosures were not found; procurement should request documentation and test evidence under NDA when appropriate. - API limitations or integration constraints - The vendor describes an "open architecture" and APIs, but public API documentation was not located during this research. Integration specifications should be requested during procurement.

Deal disqualifiers: what makes a poor fit

Procurement processes that require publicly verifiable security certifications on a vendor website without NDA access.
Organizations that require transparent, self-serve SaaS pricing and rapid, out-of-the-box deployments.
Customers specifically seeking legacy modules that are no longer available for new customers.

02Why they buy

- unique selling points supported by accessible evidence (vendor and ecosystem references) - Focus on closed-loop medication management covering prescribing (EVS), administration registration (TDR), and pharmacy information/operations (ZAIS/AIS). - Vendor states the product provides configurable medication surveillance signals that pharmacists can adapt; this is a vendor claim and should be validated during demos and reference checks. - Academic and clinical references indicate that ViPharma or related products have been used as source systems for hospital research data, supporting evidence of real-world deployments. - Where competitors have advantages - Suite vendors (ChipSoft, NEXUS) may offer broader end-to-end EPD capabilities, which can reduce integration points for organizations pursuing consolidation. - Other vendors focused on EVS/eTDR for care settings may present stronger device/offline support narratives for mobile nursing workflows.

03Field reports

Important context: review-platform coverage appears limited

Mainline review platforms (G2, TrustRadius, Gartner Peer Insights) did not yield accessible, product-specific listings for HI-Systems during this research run; name collisions and limited platform coverage for niche Dutch healthcare vendors reduce visibility on those platforms.

What can be cited as customer evidence (non-review)

Academic and clinical publications reference use of ViPharma or related products in hospital workflows and research data extraction. These references indicate real-world deployments for some Dutch hospitals and research contexts.
Vendor-authored communications (e.g., LinkedIn updates) include named customer references and integration work; these are vendor-provided signals and should be validated by direct reference checks with named customers.

Vendor / partner outcome claims (treated cautiously)

The vendor states that the suite supports medication/patient safety and configurable medication-surveillance signals; these are vendor claims and should be validated through product demonstrations and references.

Sentiment indicators

Positive (indirect): mentions in academic contexts and vendor-cited customer integrations suggest deployments in Dutch hospitals.
Negative (indirect): the vendor indicates that some legacy products are no longer available for new customers, implying migration considerations; third-party interoperability reporting indicated an outlier result for ViPharma on a measured dimension relative to competitors.

Direct quotes

Public review-platform direct quotes specific to HI-Systems were not identified in accessible searches.
The consultancy implementation report includes descriptive language about the configuration and implementation effort for ViPharma deployments; this source signals non-trivial implementation complexity.

Case Studies

- Formal, vendor-published case studies with quantified ROI were not publicly available in the pages reviewed. - Evidence of deployments (not formal case studies) - Vendor social posts reference named customers and integration projects; these items are useful for reference checks but do not include independent metrics on outcomes. - An older press article describes ViPharma supporting national medical data exchange via an LSP coupling; this demonstrates historical interoperability work but is dated and should be validated for current compatibility and maintenance. Critical evaluation: The publicly visible evidence primarily confirms deployments and integration work rather than providing quantified outcome metrics (for example, clinical or operational improvements or cost impacts). Prospective purchasers should request reference interviews and any available internal metrics from the vendor or customers.

04Best fit

Organization sizes

Best fit is likely mid-to-large Dutch healthcare organizations where medication workflows justify enterprise implementation, such as hospitals and multi-site care organizations.
The vendor operates as a smaller specialist company (reported as a small team), which can be suitable for focused national deployments but may raise scalability questions for very large international rollouts.

Industries and verticals where adoption is strongest (with customer examples)

Hospitals and institutional pharmacies. Vendor communications reference specific customers for integration projects.

Roles and personas

Decision makers: hospital pharmacy leadership, CIO/IT leadership, clinical safety/quality leadership.
End users: physicians (prescribing), pharmacists (verification and medication surveillance configuration), nurses (administration documentation).

Pain points and challenges addressed

Medication safety checks (contraindications, interactions, allergies), closed-loop visibility across prescribing and administration, and pharmacy operational workflows.

Qualification criteria: what makes a good fit

Organizations that require a dedicated medication-management platform that integrates with an existing EPD/ZIS rather than replacing it, and that can allocate internal project resources for configuration and integration.

05The pitch

What the product does (core value proposition in objective terms)

- HI-Systems provides specialist medication-management software for healthcare organizations, centered on the pharmaceutical closed loop (prescribe → verify/dispense → administer → monitor/record). - Core modules identified by the vendor include: - EVS (Elektronisch Voorschrijfsysteem / e-prescribing) for clinical and outpatient prescribing. - TDR (Toedienregistratie / administration registration) for nursing medication administration documentation. - ZAIS / AIS (hospital/institutional pharmacy information system for control, advice, finance, purchasing, distribution, inventory). - The vendor markets the suite under "ViPharma | ZAIS EVS TDR" and describes the platform as using an open architecture with web and API technologies.

Target market and market positioning

Target segments listed by HI-Systems include:
- Hospitals
- Institutional pharmacies
- Mental health (GGZ) institutions and nursing/care homes
- Pharmaceutical service providers
Positioning is focused on medication safety, workflow support, and compliance with legally defined guidelines for prescribing.

Get a comprehensive analysis of HI-Systems including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →